{"component": "definition", "props": {"groups": [{"samples": [{"hash": "7TYfZT5QQf1", "uri": "/contracts/7TYfZT5QQf1#row-territory", "label": "Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)", "score": 32.4798088074, "published": true}, {"hash": "kx2QDOgD4UT", "uri": "/contracts/kx2QDOgD4UT#row-territory", "label": "Master Research and Collaboration Agreement (Vividion Therapeutics, Inc.)", "score": 32.3073234558, "published": true}, {"hash": "9GLdmDC2Q3U", "uri": "/contracts/9GLdmDC2Q3U#row-territory", "label": "Master Research and Collaboration Agreement (Agios Pharmaceuticals Inc)", "score": 27.6009578705, "published": true}], "snippet": "means all countries in the world other than the US Territory.", "size": 26, "snippet_links": [{"key": "the-world", "type": "definition", "offset": [23, 32]}, {"key": "us-territory", "type": "clause", "offset": [48, 60]}], "hash": "1ca9b94a1ec13dbebad94caf8a86ccf4", "id": 1}, {"samples": [{"hash": "qTbRq6hcLU", "uri": "/contracts/qTbRq6hcLU#row-territory", "label": "License Agreement (Oncothyreon Inc.)", "score": 21.0, "published": true}, {"hash": "l6vqfAjqqBu", "uri": "/contracts/l6vqfAjqqBu#row-territory", "label": "Supply Agreement (Biomira Inc)", "score": 21.0, "published": true}, {"hash": "e43kYQrlo9a", "uri": "/contracts/e43kYQrlo9a#row-territory", "label": "Supply Agreement (Biomira CORP)", "score": 21.0, "published": true}], "snippet": "means all countries in the world except the NA TERRITORY;", "size": 7, "snippet_links": [{"key": "the-world", "type": "definition", "offset": [23, 32]}, {"key": "na-territory", "type": "definition", "offset": [44, 56]}], "hash": "e466c5b9bb879fae8bbe11931b15f398", "id": 2}, {"samples": [{"hash": "jkUNgHguNnz", "uri": "/contracts/jkUNgHguNnz#row-territory", "label": "Collaboration Agreement (Shire Pharmaceuticals Group PLC)", "score": 21.0, "published": true}, {"hash": "gvqdFUl3knj", "uri": "/contracts/gvqdFUl3knj#row-territory", "label": "Row Territory License Agreement (New River Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "d6MlD87B1rR", "uri": "/contracts/d6MlD87B1rR#row-territory", "label": "Row Territory License Agreement (Shire Pharmaceuticals Group PLC)", "score": 21.0, "published": true}], "snippet": "means the world, excluding the US Territory.", "size": 7, "snippet_links": [{"key": "the-world", "type": "definition", "offset": [6, 15]}, {"key": "us-territory", "type": "clause", "offset": [31, 43]}], "hash": "b6f2aea773b088162ad77f9731c90537", "id": 3}, {"samples": [{"hash": "iXFlrYpX8ED", "uri": "/contracts/iXFlrYpX8ED#row-territory", "label": "Collaboration Agreement (Biotech Spinco, Inc.)", "score": 21.0, "published": true}, {"hash": "aCHiyqOrIMW", "uri": "/contracts/aCHiyqOrIMW#row-territory", "label": "Collaboration Agreement (Facet Biotech Corp)", "score": 21.0, "published": true}, {"hash": "8eDFan9vtXQ", "uri": "/contracts/8eDFan9vtXQ#row-territory", "label": "Collaboration Agreement (Protein Design Labs Inc/De)", "score": 21.0, "published": true}], "snippet": "means all parts of the Territory not included in the North American Territory or EU Territory.", "size": 7, "snippet_links": [{"key": "the-territory", "type": "clause", "offset": [19, 32]}, {"key": "not-included", "type": "clause", "offset": [33, 45]}, {"key": "north-american-territory", "type": "definition", "offset": [53, 77]}, {"key": "eu-territory", "type": "definition", "offset": [81, 93]}], "hash": "ad73b26c25fc97d1745e6553fc9c13f2", "id": 4}, {"samples": [{"hash": "jHnit1G5Otl", "uri": "/contracts/jHnit1G5Otl#row-territory", "label": "Technology Transfer and Exclusive License Agreement (Arbutus Biopharma Corp)", "score": 33.1670074463, "published": true}, {"hash": "cNeEjE30FXy", "uri": "/contracts/cNeEjE30FXy#row-territory", "label": "License Agreement (BridgeBio Pharma, Inc.)", "score": 30.8507862091, "published": true}, {"hash": "adetwWK3Xuv", "uri": "/contracts/adetwWK3Xuv#row-territory", "label": "License Agreement (Eidos Therapeutics, Inc.)", "score": 30.8288841248, "published": true}], "snippet": "means all countries of the world outside of the Territory.", "size": 6, "snippet_links": [{"key": "the-world", "type": "definition", "offset": [23, 32]}, {"key": "outside-of-the-territory", "type": "clause", "offset": [33, 57]}], "hash": "f5c0a9c8d6eb11b822f83b5bdfeb6e3d", "id": 5}, {"samples": [{"hash": "g5TYfTvULRw", "uri": "/contracts/g5TYfTvULRw#row-territory", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.4072551727, "published": true}, {"hash": "idtJNVrIV8W", "uri": "/contracts/idtJNVrIV8W#row-territory", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.3305950165, "published": true}, {"hash": "dtcFeYHN9oB", "uri": "/contracts/dtcFeYHN9oB#row-territory", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 26.7878170013, "published": true}], "snippet": "means all countries of the world other than China.", "size": 6, "snippet_links": [{"key": "the-world", "type": "definition", "offset": [23, 32]}], "hash": "6c64b0f952ca63397128efc8721aa20f", "id": 6}, {"samples": [{"hash": "l2q3fIV9JxT", "uri": "/contracts/l2q3fIV9JxT#row-territory", "label": "Royalty Agreement", "score": 31.3408622742, "published": true}, {"hash": "hixE1Sd7Dl2", "uri": "/contracts/hixE1Sd7Dl2#row-territory", "label": "Royalty Purchase Agreement", "score": 31.3408622742, "published": true}, {"hash": "cUfGETCmePS", "uri": "/contracts/cUfGETCmePS#row-territory", "label": "Royalty Purchase Agreement (Titan Pharmaceuticals Inc)", "score": 22.8754272461, "published": true}], "snippet": "has the meaning set forth in the Vanda Sublicense.", "size": 5, "snippet_links": [{"key": "vanda-sublicense", "type": "definition", "offset": [33, 49]}], "hash": "e07f7fcc5f3c2d145dd4f70e8f0843c8", "id": 7}, {"samples": [{"hash": "8XxQElTBgLG", "uri": "/contracts/8XxQElTBgLG#row-territory", "label": "License and Collaboration Agreement (Ovid Therapeutics Inc.)", "score": 28.2717323303, "published": true}, {"hash": "7QX0wINzbpz", "uri": "/contracts/7QX0wINzbpz#row-territory", "label": "License and Collaboration Agreement (Ovid Therapeutics Inc.)", "score": 28.2142372131, "published": true}, {"hash": "2q6IGzYY5NL", "uri": "http://investors.ovidrx.com/static-files/b343e4ef-c846-44df-b4f0-37d8b6372a3e", "label": "investors.ovidrx.com", "score": 10.1704311371, "published": false}], "snippet": "means those countries in the Territory other than Japan and the Core Orphan Territory countries. For clarity, once a country becomes a country within the Extended Takeda Territory or the Extended Ovid Territory it shall cease to be a country within the ROW Territory.", "size": 3, "snippet_links": [{"key": "in-the-territory", "type": "clause", "offset": [22, 38]}, {"key": "for-clarity", "type": "clause", "offset": [97, 108]}, {"key": "takeda-territory", "type": "definition", "offset": [163, 179]}, {"key": "ovid-territory", "type": "definition", "offset": [196, 210]}], "hash": "42556a67a15709e7eb20027d4a97b2f6", "id": 8}, {"samples": [{"hash": "7EXucjna12V", "uri": "/contracts/7EXucjna12V#row-territory", "label": "Co Development and License Agreement (Cell Therapeutics Inc)", "score": 22.3141689301, "published": true}, {"hash": "4neMe7nDRic", "uri": "http://investors.ctibiopharma.com/static-files/7a001e84-ab15-47b2-b75e-2a9224d82043", "label": "investors.ctibiopharma.com", "score": 9.9637231827, "published": false}, {"hash": "iStkETmj8Uv", "uri": "https://cbc.gcs-web.com/static-files/7a001e84-ab15-47b2-b75e-2a9224d82043", "label": "cbc.gcs-web.com", "score": 9.7980833054, "published": false}], "snippet": "means worldwide except the Licensed Territory.", "size": 3, "snippet_links": [{"key": "licensed-territory", "type": "definition", "offset": [27, 45]}], "hash": "40ef13ad559322cdbb6b77bfc747c777", "id": 9}, {"samples": [{"hash": "l14H1k1cPVM", "uri": "/contracts/l14H1k1cPVM#row-territory", "label": "License and Collaboration Agreement (Cephalon Inc)", "score": 21.0, "published": true}, {"hash": "4akWDQoelkG", "uri": "/contracts/4akWDQoelkG#row-territory", "label": "License and Collaboration Agreement (Alkermes Inc)", "score": 18.0, "published": true}], "snippet": "means all countries in the world, other than the Territory.", "size": 3, "snippet_links": [{"key": "the-world", "type": "definition", "offset": [23, 32]}, {"key": "the-territory", "type": "clause", "offset": [45, 58]}], "hash": "65c2f650f5f154f85e986c4ea0868ed9", "id": 10}], "next_curs": "CloSVGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjYLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIWcm93LXRlcnJpdG9yeSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means all countries in the world other than the US Territory.", "size": 122, "title": "ROW Territory", "id": "row-territory", "examples": ["Unless the Parties agree to a single Designated Manufacturer under Section 4.4.1, AstraZeneca shall negotiate in good faith and enter into an agreement with a Designated Manufacturer for the Manufacture and supply of such quantities of Collaboration Compound and Collaboration Product as are necessary for AstraZeneca to perform its obligations under the Development Plan (i.e., with respect to the <strong>ROW Territory</strong>).", "The costs of retaining the laboratory will be included in Cost of Goods for the US Territory and will be borne by the Party whose evaluation of the applicable shipment of Compound or Collaboration Product is mistaken in the <strong>ROW Territory</strong>.", "AstraZeneca shall use Commercially Reasonable Efforts to apply for and obtain Regulatory Approval of the Collaboration Product in the <strong>ROW Territory</strong>, and \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 shall use Commercially Reasonable Efforts to apply for and obtain Regulatory Approval of the Collaboration Product in China, in each case, as soon as reasonably practicable.", "All Commercialization costs in the <strong>ROW Territory</strong> shall be borne [***] by Celgene.", "Jounce will reasonably cooperate with Celgene in such Development and Commercialization activities in the <strong>ROW Territory</strong> in accordance with Section 2.2.3 provided, however, that if such cooperation will cause Jounce to incur material Direct Costs (including Out-of-Pocket Costs), then Celgene shall reimburse such costs to the extent approved in advance by Celgene.", "Celgene shall bear one hundred percent (100%) of any Developments costs it incurs solely for ROW Administration that are included as efficacy data (and not solely safety data) intended to be included in Regulatory Filings for Regulatory Approval of Co-Co in the <strong>ROW Territory</strong> (\u201cROW Development Costs\u201d).", "Except for the specific responsibilities allocated to \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 as set forth in the Development Plan with respect to Development activities intended to support obtaining Regulatory Approval for Collaboration Products or Diagnostic Products in China, AstraZeneca will be responsible for performing all Development activities for the purpose of obtaining Regulatory Approval for Collaboration Product and Diagnostic Products in the <strong>ROW Territory</strong>.", "On a Co-Co Product-by-Co-Co Product basis, Celgene shall make the following sales milestone payments to Jounce that are set forth below upon the first achievement by or on behalf of Celgene, its Affiliates or Sublicensees of the sales milestone events (\u201cSales Milestone Events\u201d) set forth below with respect to sales of such Co-Co Product in the <strong>ROW Territory</strong>.", "If and at such time as the JCC deems appropriate, the JCC shall discuss in good faith any branding and/or co-branding of the Co-Co Products to be used in connection with the Commercialization of Co-Co Products both in the United States and the <strong>ROW Territory</strong>, and the Parties will enter into appropriate trademark licensing agreements to achieve the foregoing.", "Celgene shall be the Development Lead Party, the Commercialization Lead Party and the Regulatory Lead Party in the <strong>ROW Territory</strong>."], "related": [["us-territory", "U.S. Territory", "U.S. Territory"], ["licensed-territory", "Licensed Territory", "Licensed Territory"], ["territory", "Territory", "Territory"], ["collaboration-product", "Collaboration Product", "Collaboration Product"], ["union-territory", "Union territory", "Union territory"]], "related_snippets": [], "updated": "2025-09-25T05:32:03+00:00"}, "json": true, "cursor": ""}}